1. Home
  2. TNET vs CRNX Comparison

TNET vs CRNX Comparison

Compare TNET & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNET
  • CRNX
  • Stock Information
  • Founded
  • TNET 1988
  • CRNX 2008
  • Country
  • TNET United States
  • CRNX United States
  • Employees
  • TNET 5400
  • CRNX N/A
  • Industry
  • TNET Business Services
  • CRNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TNET Consumer Discretionary
  • CRNX Health Care
  • Exchange
  • TNET Nasdaq
  • CRNX Nasdaq
  • Market Cap
  • TNET 3.4B
  • CRNX 2.8B
  • IPO Year
  • TNET 2014
  • CRNX 2018
  • Fundamental
  • Price
  • TNET $68.47
  • CRNX $33.77
  • Analyst Decision
  • TNET Hold
  • CRNX Strong Buy
  • Analyst Count
  • TNET 3
  • CRNX 7
  • Target Price
  • TNET $89.50
  • CRNX $74.33
  • AVG Volume (30 Days)
  • TNET 396.4K
  • CRNX 1.1M
  • Earning Date
  • TNET 10-24-2025
  • CRNX 11-11-2025
  • Dividend Yield
  • TNET 1.61%
  • CRNX N/A
  • EPS Growth
  • TNET N/A
  • CRNX N/A
  • EPS
  • TNET 2.85
  • CRNX N/A
  • Revenue
  • TNET $4,993,000,000.00
  • CRNX $1,392,000.00
  • Revenue This Year
  • TNET $2.47
  • CRNX $489.51
  • Revenue Next Year
  • TNET $3.23
  • CRNX $661.93
  • P/E Ratio
  • TNET $24.02
  • CRNX N/A
  • Revenue Growth
  • TNET 0.73
  • CRNX 0.51
  • 52 Week Low
  • TNET $62.55
  • CRNX $24.10
  • 52 Week High
  • TNET $99.78
  • CRNX $62.53
  • Technical
  • Relative Strength Index (RSI)
  • TNET 48.43
  • CRNX 56.44
  • Support Level
  • TNET $67.36
  • CRNX $33.19
  • Resistance Level
  • TNET $71.75
  • CRNX $37.23
  • Average True Range (ATR)
  • TNET 1.91
  • CRNX 1.45
  • MACD
  • TNET -0.14
  • CRNX 0.11
  • Stochastic Oscillator
  • TNET 20.16
  • CRNX 52.12

About TNET TriNet Group Inc.

Trinet Group Inc outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Share on Social Networks: